Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

GE to Invest $1B in Molecular Imaging, Diagnostics

Photonics.com
Sep 2011
CHALFONT ST. GILES, England, Sept. 16, 2011 — GE Healthcare is set to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as in the company’s technologies for the manufacture of biopharmaceuticals and for cancer research.

Announced alongside a $100 million open innovation challenge in New York, the billion dollar investment crosses all lines of GE Healthcare’s global business, and will enable the company to bring the most promising cancer ideas to market, it announced.

“We are committed to tackling cancer. However, with a disease as complex and multifaceted as cancer, solutions need to be equally multifaceted and even more integrated, combining imaging, molecular diagnostics and healthcare IT,” said John Dineen, president and CEO of GE Healthcare.

GE Healthcare offers a wide portfolio for oncology and a strategy that combines cellular research, medical imaging, laboratory diagnostics, biopharmaceutical manufacturing technologies and information technology. These technologies help increase researchers’ understanding of the causes and progression of cancer and help physicians make more personalized cancer treatment and man­agement decisions, while improving clinical outcomes and accelerating the delivery of care.

For more information, visit: www.gehealthcare.com  


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.